Curebase Appoints Scott Dixon as Chief Commercial Officer

Curebase announces that Scott Dixon has joined the company as Chief Commercial Officer, bringing deep commercial and life sciences software experience at a pivotal moment in the company's growth. He will lead commercial strategy as Curebase scales its next-gen eClinical platform and deepens partnerships with sponsors, CROs, and research sites.

Curebase's modern eClinical platform brings together ePRO, eConsent, EDC, recruitment, and site technology in a single system that helps study teams launch trials faster, improve data quality, and deliver a better participant experience. Scott will be focused on expanding adoption of the platform and demonstrating its incredible impact on trial timelines, quality, and scalability.

A Proven Commercial Leader

"Scott has spent his career helping life science organizations modernize how they run clinical trials. His experience building high performing commercial teams and bringing innovative technology to market makes him the ideal leader to help guide Curebase into our next phase of growth."— Storm Stillman, Chief Executive Officer of Curebase

Dixon brings extensive experience in life sciences and healthcare technology, where he has led go to market strategy, built and scaled commercial organizations, and partnered closely with sponsors and CROs. He will work with Curebase's customers to show how the platform can simplify trial operations, improve data quality, and enhance the participant experience.

Looking Ahead

"I am excited to join Curebase at such an important time for both the company and the industry. Sponsors, CROs, and sites are looking for modern, software-driven ways to conduct studies with less friction, and Curebase's platform is uniquely positioned to meet that need."— Scott Dixon, Chief Commercial Officer of Curebase